Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 57

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 east cases samples transmission sequences vaccines korea mouse DPP4 failure hajj years CI cities UAE-HKU23
2 mers-cov mers-cov camels humans genome vaccine outbreak lung receptor acute pilgrims = 95 jeddah dccov
3 middle saudi antibodies camels genomes neutralizing south mice binding distress influenza % united arab emirates incidence perception
4 respiratory patients dromedaries dromedary camels strains protein south korea hdpp4 bat pneumonia mass age emirates 2014 dccov uae-hku23
5 coronavirus arabia dromedary animals phylogenetic responses 2015 pathogenesis cells fever returning aged arab infectious diseases environmental
6 syndrome infection serum camel isolates effective MERS model HKU4 acute respiratory distress syndrome gatherings male united makkah preventive behaviours
7 severe saudi arabia sera contact strain m336 korean chadox1 cell multiorgan hajj pilgrims CFR % singapore nursing
8 spread health positive virus recombination monoclonal 186 transgenic RBD pregnant respiratory viruses HEV aware uptodate students
9 middle east healthcare mers-cov dromedary gene activity republic mouse model HKU5 outcomes mass gatherings females slaughterhouse articles nursing students
10 2012 reported swabs human genetic mabs hospitals chadox1 mers spike cough travellers SEYLL 0.01 province behaviours
11 disease care nasal reservoir african RBD search rhesus entry respiratory failure mecca ± GCC diseases risk perception
12 rate clusters assay mers‐cov sequencing development basic replication lines renal viruses MERS-HCP milk spatiotemporal codon
13 countries transmission collected zoonotic sequence subunit government lungs amino presentation umrah CONCLUSION cws waterpipe usage
14 emerging exposure ELISA animal arabian fusion incubation vivo peptidase death gathering males kenya riyadh biocontainment
15 recent mers-cov infection dromedary camels source clade induced number mers-cov expression patient pilgrimage SARS-HCP raw temporal surfaces
16 deaths case serum samples species lineages safe reproduction human protein underlying surveillance score herders public immunity
17 high settings prevalence direct distinct receptor-binding guidelines pulmonary dipeptidyl reaction influenza a study slaughterhouse workers religious 59
18 global hospital camel role showed domain largest pathology pachypus illness 2 groups aor health contaminated
19 cases confirmed mers-cov antibodies natural viruses candidate nosocomial challenge residues day pathogens website = place coronavirus infections
20 infection % detected llamas peninsula potent nosocomial infections tissue hcov-emc mild respiratory symptoms onset < searches ecov
21 MERS workers sheep primary EMC induce point LCA60 MERS-27 polymerase travelers SK hcws regional required
22 SARS 1 nasal swabs host full immune superspreading KI inhibit admitted active surveillance non-outbreak UAE seasonality knowledge
23 current respiratory antibody zoonotic transmission phylogenetic analysis spike model rabbits cell lines pregnancy case 1 arabs blood yrs bias
24 caused contacts assays understood recombinants antibodies vs. protected expressed woman awareness bedouins general eastern province broader
25 fatality risk neutralization potential amibara monoclonal antibodies period permissive host outcome UK non-saudi zoonotic guidance saudi pilgrims
26 review middle evidence approach circulating anti-mers-cov control mdpp4 dipeptidyl peptidase 4 kidney muslims significantly iran 2015a betacoronavirus
27 mortality risk factors bactrian sporadic genomic receptor-binding domain persons macrophages critical cardiac annual METHODS slaughter areas contamination
28 middle east respiratory syndrome coronavirus data test intermediate analysis 588-fc RRT hdpp4 ki T. multi-organ visiting adults plaque community A1
29 reported factors tested alpacas similar S377 republic of korea virus replication hku8r-cov progressive hajj pilgrimage demographic confidence public health environmental circumstances
30 infections suspected > mers‐cov. sequenced immunized manage rhesus macaques CD26 multiorgan failure muslim non-bedouin provinces saudi arabia suite
31 coronaviruses laboratory-confirmed seroprevalence bats mers-cov sequences antibody occurred pyroptosis sinicus supportive corona viruses hospitalized burnetii arabia netherlands
32 including KSA found shed orf4b develop coronavirus infection marmosets ty-batcov acute respiratory illness england hepatitis council importation automated
33 clinical september infection evidence cultures approved system macaques bind respiratory australian p<0.001 rt-iipcr progression mapping
34 sars-cov identified % infectious virus competence mice infected models hamster chain karbala 0.001 general population risk 1384
35 mortality rate results seropositive pigs human humoral infectious dipeptidyl glycoprotein MERS ILI versus workers td-rs clinical practice
36 virus middle east respiratory syndrome coronavirus goats epidemiology obtained vaccinated patient disease cellular medical population statistically laikipia spatial RT‐PCR
37 acute respiratory syndrome east farm explain deletions promising parameters viral susceptible treatment annually referral rt-qpcr global spread programmes
38 europe epidemiologic sensitivity arabian peninsula calu-3 inhibitors credibility interval reduced viral entry present home $ concerned OCT removal
39 health testing results hypothesis reading neutralizing activity initiated inflammation MERS-4 pregnant woman compliance onset to 1.5 hoses MHV-A59
40 drugs infections immunofluorescence animal species genome sequences therapeutic turning epithelial polymorphisms transcriptase FLU ORA county zumla blot
41 combination 13 dubai infected formed mab 0.000 adaptive hcd26 rare rhinovirus older drinking hafr enhancing
42 international coronavirus middle secretions ex-vivo peptides notified intramuscular ancestral supportive care rhinoviruses confirmation wore sectors triggered
43 human july coronavirus act similarity nbs team transgenic mice bat cells clinical presentation influenza viruses days blood samples 2015c circumstances
44 ‘ health-care bactrian camels undetected virus treat mers-cov outbreak hamsters R. rla-mers-s iranian RESULTS disease transmission 2013a inactivate
45 agents 20 syndrome poorly africa monoclonal antibody credibility infection EMC/2012 difficulties proactive version living hui narrower
46 arabia healthcare workers study dromedarius related potently middle east respiratory coronavirus 4 surface pregnant women millions SUPPLEMENTARY abattoir memish camel-associated
47 mechanisms 31 respiratory combined confirming inhibitory relationships cells host cells eventually respiratory jews seronegative region distributions
48 named diagnosed celisa domestic calu-3 cells mers-cov R(0 ex vivo utilize hypertension tested users seropositivity group preventive
49 saudi arabia aimed nose data betacoronaviruses MERS opportunity depletion tylonycteris clinical 2013 mers-non-hcp seroprevalence eastern education
50 focus syndrome NP peninsula organisms bound hospital infection benefit abramus breath pilgrim online version camels health risk survey